雄激素受体及前列腺特异性抗原基因多态性与前列腺癌易感性
被引量:2
摘要
雄激素受体(AR)基因CAG重复多态性与前列腺特异性抗原(PSA)基因ARE I G/A多态性及其交互作用影响了前列腺癌的发病风险及血清PSA水平的变化,本文就近年来AR基因与PSA基因多态性和前列腺癌易感性间的关系作一综述,并着重讨论了AR基因与PSA基因多态性交互作用对前列腺癌发病风险的影响。
出处
《国际泌尿系统杂志》
2006年第2期213-215,共3页
International Journal of Urology and Nephrology
参考文献21
-
1Greenlee RT, Murray T ,Thun M, et al. Cancer statistics, CA Cancer J Clin, 2001,51:15 -36.
-
2Jemal A, Tiwari R, Murray T, et al. Cancer statistics, CA Cancer J Clin, 2004,54( 1 ) :8229.
-
3顾方六.影响前列腺癌发病的因素[J].中华泌尿外科杂志,2000,21(5):261-262. 被引量:25
-
4Wilding G . The importance of stefiod hormones in prostate cancer.Cancer Surv, 1992,14 : 113.
-
5Ross RK ,Paganini - Hill A ,Henderson BE. The etiology of prostate cancer. What does the epidemiology suggest? Prostate,1983,4(4) :333.
-
6Watkins WS, Bamshad M, Jord LB. Population genetics of trinudeo tide repeat polymorphisms. Hum Mol Genet, 1995,4 ( 10 ) : 1485 -1491.
-
7Brown, C J, Goss SJ, Lubahn DB, et al. Androgen receptor locus on the human X chromosome: regional localization to Xqll -12 and description of a DNA polymorphism, Am J Hum Genet, 1989,44:264- 269.
-
8Huang SP,Chou YH,Chang WS,et al. Androgen receptor gene polymorphism and prostate cancer in Taiwan. J Formos Med Assoc,2003,102(10) :680 -686.
-
9Mishra D,Thangaraj K,Mandhani A,et al. Is reduced CAG repeat length in androgen receptor gene associated with risk of prostate cancer in Indian population? Clin Genet,2005,68 (1) :55 -60.
-
10Nam RK,Elhaji Y,Krahn MD,et al. Significance of the CAG repeat polymorphism of the androgen receptor gene in prostate cancer progression. J Urol, 2000,164(2) :567 -572.
二级参考文献16
-
1Stamey TA, Yang N, Hay AR, et al. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med, 1987, 317: 909-916.
-
2Mitka M. Is PSA testing still useful? JAMA, 2004, 292:2326-2327.
-
3Stamey TA, Caldwell M, McNeal JE, et al. The prostate specific antigen era in the United States is over for prostate cancer:what happened in the last 20 years? J Urol, 2004, 172:1297-1301.
-
4Sakr WA, Grignon DJ, Haas GP, et al. Age and racial distribution of prostatic intraepithelial neoplasia. Eur Urol, 1996,30: 138-144.
-
5Rich AR. On the frequency of occurrence of occult carcinoma of the prostate. J Urol, 1935,33: 215.
-
6McNaughton Collins M, Ransohoff DF, Barry MJ. Early detection of prostate cancer. Serendipity strikes again. JAMA,1997, 278: 1516-1519.
-
7Punglia RS, DAmico AV, Catalona WJ, et al. Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen. N Engl J Med, 2003, 349: 335-342.
-
8CorreaCerroL,WohrG,HausslerJ ,etal.(CAG)nCAAandGGNrepeatsinthehumanandrogenreceptorgenearenotassociatedwithprostatecancerinaFrenchGerman population[].EurJHumGenet.1999
-
9Bennett CL,Price DK,Kim S,et al.Racial variation in CAG repeat lengths within the androgen receptor gene among prostate cancer patients of lower socioeconomic status[].Journal of Clinical Oncology.2002
-
10Stanford JL,Just JJ,Gibbs M,et al.Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk[].Cancer Research.1997
共引文献36
-
1谢青南.103例前列腺癌的诊断分析[J].河南外科学杂志,2004,10(4):82-82.
-
2曹开源,戴淑琴,徐霖中,袁广卿,黄小荣,丘少鹏,郭琳洁.中国人前列腺特异膜抗原基因真核表达载体的构建和序列测定[J].中国病理生理杂志,2004,20(6):1009-1012. 被引量:1
-
3徐卓群,徐进宇,仇学文,胡强,王志荣,阮钧,诸明,徐则乔,张坚.无锡市112例临床前列腺癌分析[J].中华男科学杂志,2004,10(10):779-780.
-
4王志强,梁大用.晚期前列腺癌的内分泌及放射治疗探讨[J].宁夏医学杂志,2005,27(4):219-221. 被引量:2
-
5王少波,沈柏华.泌尿男生殖系肿瘤发病情况的变迁[J].浙江临床医学,2005,7(6):615-615. 被引量:5
-
6戴淑琴,孙秀英,王军业,曹开源,何丽容,徐霖,袁广卿.前列腺特异膜抗原基因的克隆和真核表达[J].中国肿瘤临床与康复,2005,12(4):289-292.
-
7买铁军,汪欣,郭应禄.雄激素受体信号通路研究进展[J].中华泌尿外科杂志,2005,26(10):717-719. 被引量:8
-
8程学军,于艳.高脂饮食与前列腺癌发病的关系[J].国外医学(老年医学分册),2006,27(2):86-89. 被引量:1
-
9田黎明,曾宪玉,王玮蓁,王辉,冷明,余艳,梁文,薛飞.雄激素受体基因CAG多态性与痤疮中医分型的相关性研究[J].中国皮肤性病学杂志,2006,20(5):306-308. 被引量:3
-
10蔡振,周华设.比卡鲁胺治疗晚期前列腺癌对血清PSA、f-PSA含量影响[J].实用诊断与治疗杂志,2006,20(6):401-402. 被引量:2
同被引文献78
-
1管同郁,李鸣,刘三震,李瑶,周利群,那彦群.CYP1A1与GSTM1基因多态性与前列腺癌易感性的关系[J].中华泌尿外科杂志,2004,25(10):697-700. 被引量:6
-
2古力米热,李鸿伟,王军起,龚侃,那彦群.维吾尔族前列腺癌与雄激素受体CAG重复多态性的关系[J].中华医学遗传学杂志,2004,21(4):415-416. 被引量:3
-
3管同郁,李鸣,那彦群.生物转化酶基因多态性与前列腺癌易感性的研究[J].中华外科杂志,2005,43(22):1467-1470. 被引量:1
-
4张军,吕朝晖,母义明,潘长玉.前列腺癌原癌基因[J].医学综述,2006,12(12):725-727. 被引量:3
-
5Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2010. CA Cancer J Clin, 2011, 61:133-134.
-
6Ma RW, Chapman K. A systematic review of the effect of dietin prostate cancer prevention and treatment. J Hum Nutr Diet, 2009,22 : 187-199.
-
7Lichrenstein P, holm NV, Verkasalo PK, et al. Environment and heritable factors in the causation of Cancer: analysis of co- hort of twins from Sweden. denmark, and finland. N Eng I J, 2002,343:78-85.
-
8Locke JA, Br:chovsky N. Prostatecancer: finasteride extends PSAdoubling time during intermittent hormone therapy. Can J Urol, 2010, 17:5162-5169.
-
9Wellcome Trust Case Control Consortium. Genome-wide associa- tion study of 14,000 cases of seven common diseases and 3, 000 shared controls. Nature, 2007, 447 : 661-678.
-
10Liu M, Kurosaki T, Suzuki M, et al. Significance of common variants on human chromosome 8 q24 in relation to the risk of prostate cancer in native Japanese men. BMC Genetics, 2009, 10: 37.
二级引证文献4
-
1张翠,毕宇,马晓云.血清PSA、PAP联合检测对前列腺癌的诊断价值及雌激素对其的影响[J].国际医药卫生导报,2016,22(19):3011-3014. 被引量:1
-
2陶红,陈文军.血清PSA、PAP联合检测对前列腺癌诊断价值及雌激素对其影响研究[J].中国生化药物杂志,2017,37(5):365-367. 被引量:4
-
3孙健,孙承文,丁锡奇.腹腔镜下前列腺癌根治术结合内分泌辅助治疗高危前列腺癌的效果[J].实用临床医药杂志,2017,21(11):84-86. 被引量:15
-
4刘洪利,李军红,张希栓,王军利.前列腺穿刺活检标本中泡沫样腺癌的临床病理学特点及免疫组化染色表达特征[J].癌症进展,2017,15(8):950-952. 被引量:5
-
1尼杰,只向成.雄激素受体在Her-2过表达型乳腺癌中的表达及其预后意义[J].肿瘤,2016,36(11):1212-1217. 被引量:5
-
2杨杰(综述),钱立新(审校).GSTM_1、GSTT_1基因多态性与前列腺癌易感性[J].中国男科学杂志,2005,19(4):62-64.
-
3陈健,张旭,田茹,刘艺,董红梅,郭瑞峰,梁化印.雄激素受体在乳腺癌中的表达及其与雌、孕激素受体和HER2的关系[J].中华病理学杂志,2010,39(11):743-746. 被引量:7
-
4彭燕.三阴性乳腺癌潜在的肿瘤预后生物标志(英文)[J].北京大学学报(医学版),2012,44(5):666-672. 被引量:5
-
5王海,凌扬,盛桂凤,刘永萍,周林艳,张亚平.乳腺癌组织雄激素受体表达及其与启动子甲基化的关系[J].中国临床保健杂志,2016,19(6):595-598.
-
6杨金辉,白铁男,王思成,胡海龙,庄士超,韩瑞发.PSMA和AR在膀胱移行细胞癌中的表达及其相关性研究[J].天津医药,2010,38(9):737-739.
-
7唐乐辉,陈浪,陈有军.乳腺癌中基质金属蛋白酶和性激素受体的表达及其与淋巴结转移的相关性[J].现代医药卫生,2012,28(23):3537-3539. 被引量:2
-
8高琪琪,金晓东,任国平,向华,王波.LSD1和AR在前列腺癌中的表达及其意义[J].实用肿瘤杂志,2011,26(1):21-24. 被引量:4
-
9李靖华,柳克晔,王晓春,杨季红.乳腺癌中雄激素受体的表达及临床意义[J].河北医药,2010,32(15):2008-2009. 被引量:2
-
10贺松琴,曹广文.雄激素非依赖性前列腺癌发生的分子机制[J].国外医学(泌尿系统分册),2005,25(6):811-815. 被引量:5